^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    dexamethasone injection

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    Steroid receptor agonist, GCR agonist
    Related drugs:
    Associations

    News

    Trials
    1m
    MANTRA: Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy (clinicaltrials.gov)
    P=N/A, N=80, Recruiting, Fundacio Puigvert | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dexamethasone injection • ondansetron intravenous
    1m
    Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty: A Randomized Double-Blind Trial (clinicaltrials.gov)
    P=N/A, N=198, Recruiting, Poznan University of Medical Sciences | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dexamethasone injection
    1m
    Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery (clinicaltrials.gov)
    P=N/A, N=588, Completed, Beijing Tiantan Hospital | Recruiting --> Completed | Trial completion date: Dec 2026 --> May 2026 | Trial primary completion date: Nov 2026 --> Apr 2026
    Trial completion • Trial completion date • Trial primary completion date
    |
    dexamethasone injection
    1m
    ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee Arthroplasty (clinicaltrials.gov)
    P=N/A, N=120, Not yet recruiting, Poznan University of Medical Sciences
    New trial
    |
    dexamethasone injection
    1m
    Case Report: Longitudinal analysis of local immunoregulatory mediators in a DLBCL vitreoretinal lymphoma receiving local chemotherapy. (PubMed, Front Med (Lausanne))
    A patient in their 70s with unilateral VRL underwent nine serial vitreous samplings over 12 weeks of IVT therapy with methotrexate (460 μg/injection) and dexamethasone (0.4 mg/injection)...These findings propose a novel framework for integrating intraocular immunomonitoring into personalized therapeutic strategies and deepen our understanding of the complex tumor-immune microenvironment in vitreoretinal lymphoma. As derived from a single case, these observations are hypothesis-generating and require confirmation in larger cohorts.
    Journal
    |
    IFNG (Interferon, gamma) • IL6 (Interleukin 6) • HGF (Hepatocyte growth factor) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CXCL12 (C-X-C Motif Chemokine Ligand 12) • CXCL9 (Chemokine (C-X-C motif) ligand 9) • CXCL13 (Chemokine (C-X-C motif) ligand 13) • IL10 (Interleukin 10) • CCL4 (Chemokine (C-C motif) ligand 4) • FGF2 (Fibroblast Growth Factor 2) • IL17A (Interleukin 17A) • IL1R1 (Interleukin 1 receptor, type I) • IL16 (Interleukin 16)
    |
    dexamethasone injection
    2ms
    TRIlogy-7: A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned (clinicaltrials.gov)
    P3, N=1000, Not yet recruiting, Janssen Research & Development, LLC
    New P3 trial
    |
    lenalidomide • bortezomib • Darzalex (daratumumab) • ramantamig (JNJ-5322) • dexamethasone injection
    2ms
    Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis (clinicaltrials.gov)
    P1, N=21, Completed, M.D. Anderson Cancer Center | Active, not recruiting --> Completed | Trial completion date: May 2027 --> Jun 2026 | Trial primary completion date: May 2027 --> Jun 2026
    Trial completion • Trial completion date • Trial primary completion date
    |
    Ninlaro (ixazomib) • Darzalex (daratumumab) • dexamethasone injection
    2ms
    Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block (clinicaltrials.gov)
    P1, N=111, Completed, Assiut University | Not yet recruiting --> Completed
    Trial completion
    |
    dexamethasone injection
    2ms
    ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma (clinicaltrials.gov)
    P2, N=160, Not yet recruiting, Massachusetts General Hospital | Initiation date: Apr 2026 --> Aug 2026
    Trial initiation date
    |
    clonoSEQ®
    |
    lenalidomide • bortezomib • Elrexfio (elranatamab-bcmm) • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
    2ms
    Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial. (PubMed, Lancet)
    Mezigdomide-carfilzomib-dexamethasone provided a significant PFS benefit compared with carfilzomib-dexamethasone alone, with higher rates of grade 3 or 4 adverse events, including infections, which were mostly manageable with standard clinical practice and supportive care. These findings support mezigdomide-carfilzomib-dexamethasone as a clinically meaningful treatment option as early as first relapse in predominantly triple-class-exposed, anti-CD38 antibody-refractory and lenalidomide-refractory patients, a growing population with substantial unmet need.
    P3 data • Journal
    |
    IKZF1 (IKAROS Family Zinc Finger 1) • CRBN (Cereblon)
    |
    lenalidomide • carfilzomib • mezigdomide (CC-92480) • dexamethasone injection
    2ms
    DEXA-SEPSIS: Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis (clinicaltrials.gov)
    P1/2, N=102, Completed, CHA University | Recruiting --> Completed
    Trial completion
    |
    dexamethasone injection
    2ms
    Anesthetic Block of the Erector Muscles of the Lumbar Spine to Relieve Acute Lumbar Pain: Pilot Study (clinicaltrials.gov)
    P3, N=40, Recruiting, Elsan | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dexamethasone injection